Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study

Abstract
Allogeneic red blood cell transfusion is frequently used in total hip replacement surgery (THR). However, data on the prognosis of transfused patients are sparse. In this study we compared the risk of complications following THR in transfused and non-transfused patients.